US Regulators Clear GE Healthcare's $580M Purchase of Clarient

The Federal Trade Commission granted GE Healthcare early termination of the waiting period under federal law, removing antitrust barriers in the US for the deal to move ahead.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.